Skip to main content
Industry News
Mobile labs help Eli Lilly test antibody drug

Eli Lilly and Co. wants to find out if the antibody drug it has developed can prevent COVID-19 cases in nursing homes, so it is sending mobile research labs to these facilities as part of its late-stage clinical trial. Some labs have been sent to locations across the US in anticipation of COVID-19 outbreaks, and Chief Scientific Officer Dan Skovronsky said that when an outbreak occurs, the mobile lab sets up at the site, works with nursing home staff and randomizes residents and workers into the trial.

Full Story: